Navigation

Arimidex vs. Aromasin

Are Arimidex and Aromasin the Same Thing?

Arimidex (anastrozole) and Aromasin (exemestane) are nonsteroidal aromatase inhibitors used to treat breast cancer in postmenopausal women. Arimidex and Aromasin are often given to women whose cancer has progressed even after taking tamoxifen (Nolvadex, Soltamox).

What Are Possible Side Effects of Arimidex?

Common side effects of Arimidex include:

Tell your doctor if you experience serious side effects of Arimidex including:

What Are Possible Side Effects of Aromasin?

Common side effects of Aromasin include:

Tell your doctor if you have serious side effects of Aromasin including:

  • bone fractures,
  • mental/mood changes (such as depression, anxiety),
  • vaginal bleeding,
  • persistent nausea or vomiting,
  • unusual tiredness,
  • dark urine, or
  • yellowing eyes or skin.

What is Arimidex?

Arimidex (anastrozole) is a non-steroidal aromatase inhibitor used to treat breast cancer in postmenopausal women. Arimidex is often given to women whose cancer has progressed even after taking tamoxifen (Nolvadex, Soltamox). Arimidex is available in generic form.

What is Aromasin?

Aromasin (exemestane) is an antineoplastic (anticancer) agent used to treat breast cancer in postmenopausal women. Aromasin is often given to women whose cancer has progressed even after taking tamoxifen (Nolvadex, Soltamox) for 2 to 3 years.

What Drugs Interact With Arimidex?

Arimidex may interact with tamoxifen or an estrogen medication (such as hormone replacement therapy, estrogen creams, or birth control pills, injections, implants, skin patches, and vaginal rings)..

What Drugs Interact With Aromasin?

Aromasin may interact with rifampin, rifabutin, rifapentine, St. John's wort, seizure medications, bosentan, dexamethasone, barbiturates, HIV medications, or medicines to treat narcolepsy.

How Should Arimidex Be Taken?

The dose of Arimidex is one 1 mg tablet taken once a day. For patients with advanced breast cancer, the medication should be continued until tumor progression.

How Should Aromasin Be Taken?

The recommended dose of Aromasin in early and advanced breast cancer is one 25 mg tablet once daily after a meal.

Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.